Concepedia

Claudio Martines

CM

6

Publications

237

Citations

6

H-Index

2018

Active since

Affiliations

International Centre for Genetic Engineering and Biotechnology(Current)

Macedonian Academy of Sciences and Arts

University of Turin

Università Cattolica del Sacro Cuore

Agostino Gemelli University Polyclinic

Claudio Martines is an author at International Centre for Genetic Engineering and Biotechnology specializing in immunology, tumor biology, and medicine.

ORCID

Top concepts

Publications per year

2018–2024

6

Publications

6

Constitutive IP3 signaling underlies the sensitivity of B-cell cancers to the Bcl-2/IP3 receptor disruptor BIRD-2

Mart Bittremieux, Rita M. La Rovere, Haidar Akl et al. · Cell Death and Differentiation · 2018 · 81 citations · Full text

B-cell receptor signaling and genetic lesions in TP53 and CDKN2A/CDKN2B cooperate in Richter transformation

Supriya Chakraborty, Claudio Martines, Fabiola Porro et al. · Blood · 2021 · 64 citations · Full text

Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphoma

Binu K. Sasi, Claudio Martines, Elena Xerxa et al. · Leukemia · 2019 · 29 citations

, , +7

Macrophage- and BCR-derived but not TLR-derived signals support the growth of CLL and Richter syndrome murine models in vivo

Claudio Martines, Supriya Chakraborty, Marija Vujovikј et al. · Blood · 2022 · 25 citations · Full text

ABT‐199 (Venetoclax), a BH3‐mimetic Bcl‐2 inhibitor, does not cause Ca<sup>2+</sup>‐signalling dysregulation or toxicity in pancreatic acinar cells

Monika A. Jakubowska, Martijn Kerkhofs, Claudio Martines et al. · British Journal of Pharmacology · 2018 · 24 citations · Full text

Rows per page

1–5 of 6